Lofepramine/L-phenylalanine

洛非帕明/L-苯丙氨酸

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLofepramine/L-phenylalanine
Drug Alias NameL-苯丙氨酸Lofepramine/PhenylalanineLofepramine●L-phenylalanine洛非帕明/苯丙氨酸Lofepramine+Phenylalanine +[15
ClassificationSmall molecules
Mechanisms of ActionMonoamine reuptake inhibitor
TargetsMonoamine transporters
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmarin Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A